⌘K

Login Start Free

Home/Insiders/Paul Andrea

PA

SEC Insider//CIK 0001863130

Paul Andrea

CIK 00018631302 companiesSAN DIEGO, CA

Transactions

12

Companies

2

Filings

6

CIK

0001863130

Recent Transactions

12 trades

Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-02-03+934,041→ 1,084,014 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2025-02-03+124,714→ 124,714 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-02-03$1.71/sh−13,230→ 1,070,784 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-02$11.54/sh−3,310→ 149,973 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-02-01+90,000→ 90,000 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-02-01+112,500→ 112,500 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-01+112,500→ 153,283 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2023-02-01+59,217→ 59,217 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-01+40,783→ 40,783 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-08-01+290,500→ 290,500 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-03-01+80,000→ 80,000 total
Award
LogicBio Therapeutics, Inc.
Employee Stock Option (Right to buy)
2021-05-17+165,000→ 165,000 total

Companies

2

Recent Filings

6

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov